Teva Pharmaceutical Industries Ltd. agreed Sunday to pay $85 million to resolve claims by the state of Oklahoma that the company’s marketing helped fuel a rise in opioid addiction. The deal comes days before Teva was set to defend itself at a landmark trial, the first to unfold out of some 2,000 lawsuits brought by states and local municipalities against pharmaceutical companies over the opioid crisis.

Source: Wall Street Journal May 26, 2019 16:07 UTC